Peter Attia· MD
in the 2003 SARS vaccine work there was some real challenges that developed with the animals with something called antibody dependent enhanced with a de where if he made just a little bit of antibody that was bad because then when you got infected with the real thing you had this antibody dependent enhancement there was a shock like picture and it was a real challenge